Kinevant Sciences, a Roivant spinout designed to test an investigational monoclonal antibody, has reported that the asset ...

Despite suffering from post-viral fatigue after having pneumonia, Queen Camilla joined King Charles, Prince William and ...

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I'm ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

Roivant said on Tuesday its drug did not meet the main goal in a mid-stage trial evaluating it in patients with a type of lung disease. The drugmaker said it will discontinue further development of ...

We live longer and longer, and as we age, a lot of us develop a series of health issues and chronic diseases, including ...

Jean C. Pfau, Ph.D. and Kinta Serve provide their perspective on asbestos, the pleural cavity, and autoimmune disease ...

A recent study in Nature Materials introduces an inhalable nanozyme treatment for viral pneumonia, showing promising results ...

Researchers are trying to get to the root of the problem in hopes of helping these patients who are suffering the longest.

A new study suggests that nicotinamide riboside (a form of vitamin B3) may reduce lung inflammation in COPD patients, with ...

Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis ...